RECRUITING

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Description

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.

Study Overview

Study Details

Study overview

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

Condition
Tardive Dyskinesia
Intervention / Treatment

-

Contacts and Locations

Brooklyn

Fermata Helath, Brooklyn, New York, United States, 10038

Garfield Heights

Charak Research Center, Garfield Heights, Ohio, United States, 44125

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Prescribed and taking an antipsychotic medication for 90-days or longer.
  • 2. Tardive Dyskinesia symptoms if present are not from Parkinsons, Tourette's syndrome, Huntington disease.
  • 3. Signed an informed consent.
  • 4. Speaks English fluently.
  • 1. Suffered a moderate or severe head injury in the last year;
  • 2. History of a learning disorder or developmental disability that would inhibit a patient from completing the TD protocol.
  • 3. Severe visual impairment that is cannot be corrected by glasses or contacts.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

iRxReminder,

Rakesh Ranjan, M.D., STUDY_DIRECTOR, Charak Research Center

Owen Muir, M.D., STUDY_DIRECTOR, Fermata Health

Study Record Dates

2024-12-31